论文部分内容阅读
目的探讨黛力新治疗老年脑卒中后抑郁的临床疗效。方法对80例患者随机分为2组,均给予脑卒中常规治疗,其中一组加服黛力新早、中午各1片,治疗前后行汉密尔顿抑郁量表(HAMD)及纳维亚神经功能缺损评分表(MESSS)进行疗效评估。结果用药6周后发现与治疗前及常规组比较,治疗组与对照组差异有统计学意义。结论黛力新对脑卒中后抑郁有较好疗效,不良反应轻。
Objective To investigate the clinical effect of Deanxit in the treatment of post-stroke depression in the elderly. Methods Eighty patients were randomly divided into two groups. All patients were given conventional treatment of stroke. One group was given Deanxit and one at midday, and the Hamilton Depression Inventory (HAMD) and Nervi nerve function defect Rating Scale (MESSS) for efficacy evaluation. Results After 6 weeks of treatment, the difference between the treatment group and the control group was found to be statistically significant compared with that before treatment and the control group. Conclusion Deanxit has better curative effect on post-stroke depression with less adverse reactions.